NuLiv Science, a company that specializes in plant-based nutraceutical ingredients, recently published a study on the effectiveness and safety of Verbasnol™ for treating moderate to severe acne in females. The study was conducted over two months and targeted adult women with poor Global Acne Grading Systems (GAGS) scores. Participants were given either Verbasnol™ capsules or a placebo for 56 days.
Results showed significant improvements in GAGS scores by day 28, with further enhancements observed by day 56. These improvements included improvements in complexion, luminosity, and overall skin quality. The CEO of NuLiv Science, Richard Wang, emphasized the importance of these findings in demonstrating the potential of incorporating Verbasnol™ into skincare formulations. He highlighted that the research data could be used by skincare and beauty brands to strengthen and differentiate their products in the market.
NuLiv Science is a Certified B-Corp that specializes in producing plant-based nutraceutical ingredients inspired by Traditional Chinese Medicine. The company collaborates with academia to develop innovative and scientifically-backed herbal wellness ingredients that support overall health and wellness. For more information about Verbasnol™ and the clinical trial, visit the NuLiv Science website.
